San Francisco-based CollabRx has launched CancerRx, an mHealth app meant to help oncologists and pathologists find appropriate oncology therapeutic options for patients.
The app provides treatment options that consider the genetics of patients' tumors. Treatment options include published clinical treatment guidelines and "beyond standard of care" medical and scientific evidence-based options. The treatment guidelines were developed by CollabRx's 75-member advisory network, comprised of physicians, scientists and researchers.
"CancerRx was developed to serve as a trusted clinical decision support tool for physicians to quickly and efficiently translate clinical research advances into practical information that can be routinely used to inform cancer treatment planning at the point of care," said Thomas Mika, chairman, president and CEO of CollabRx, in a news release.
More Articles on mHealth Apps:
BBK Worldwide Unveils 2 New Apps for Clinical Trial Patient Engagement
4 Recently Launched mHealth Apps
On Apple's Heels, Google Introduces Health, Fitness Tracking Platform